Turner et al developed a severity index for patients with AIDS that correlated with survival before the introduction of HAART. It is based on the condition that defines the onset of AIDS and the severity of complications in the 3 months after the first diagnosis of an AIDS-defining condition. The authors are from Thomas Jefferson University in Philadelphia and the New York State Department of Social Services
Diagnosis |
Group |
---|---|
Kaposi's sarcoma, no organ involvement |
1 |
herpes simplex, mucocutaneous |
1 |
disseminated tuberculosis |
1 |
Candida esophagitis |
1 |
wasting syndrome |
1 |
Salmonella sepsis |
1 |
Pneumocystis carinii pneumonia |
2 |
disseminated atypical mycobacterial infection |
3 |
Kaposi's sarcoma with organ involvement |
3 |
cryptococcosis |
3 |
herpes simplex infection with organ involvement |
3 |
disseminated cytomegalovirus infection |
3 |
cryptosporidiosis or isosporiasis |
3 |
toxoplasmosis |
3 |
disseminated histoplasmosis |
3 |
AIDS-related lymphoma |
3 |
AIDS dementia complex |
3 |
disseminated coccidioidomycosis |
3 |
progressive multifocal leukoencephalopathy |
3 |
Complications |
Severity Level |
---|---|
none within 3 month interval after onset of AIDS |
0 |
complication from the least severe level within 3 month interval after onset of AIDS |
1 |
complication from the moderately severe level within 3 month interval after onset of AIDS |
2 |
complication from the most severe level within 3 month interval after onset of AIDS |
3 |
Examples of Complication |
Severity Level |
---|---|
Candida esophagitis |
1 |
bacterial pneumonia |
1 |
pulmonary tuberculosis |
1 |
chronic mucocutaneous herpes simplex |
1 |
cutaneous Kaposi's sarcoma |
1 |
visceral Kaposi's sarcoma |
2 |
CMV retinitis |
2 |
cryptococcal meningitis |
2 |
toxoplasmosis |
2 |
disseminated tuberculosis |
2 |
respiratory failure |
3 |
AIDS dementia complex |
3 |
HIV-related cardiomyopathy |
3 |
AIDS-associated lymphoma |
3 |
CMV colitis |
3 |
|
Severity Level of Subsequent Complications |
|||
---|---|---|---|---|
AIDS Defining Diagnosis Group |
0 (none) |
1 (mild) |
2 (moderate) |
3 (severe) |
Group 1 |
A |
C |
D |
D |
Group 2 |
B |
C |
D |
D |
Group 3 |
C |
C |
D |
D |
Index |
Severity |
50% Survival |
---|---|---|
A |
minimal |
43 months |
B |
mild to moderate |
22 months |
C |
moderate to marked |
18 months |
D |
most |
13 months |
from Figure 3, page 1067
Limitations:
• With the development of highly active anti-retroviral therapy (HAART) the survival of patients has markedly improved.
Purpose: To determine the illness severity of a patient with AIDS using the severity index of Turner et al.
Specialty: Infectious Diseases
Objective: severity, prognosis, stage
ICD-10: B20,